Skip to main content
. 2023 Oct 16;52(1):1–10. doi: 10.1097/CCM.0000000000006058

Table 2.

Number of Patients Who Received Organ Support

Vital Organ Support Patients Receiving Vital Organ Support Women
Receiving Vital Organ Support
Men
Receiving Vital Organ Support
Invasive ventilation (n = 697,785) 225,306 (32.2%) 78,510 (25.7%) 146,796 (37.3%)
Noninvasive ventilation (n = 583,077) 62,849 (10.8%) 27,221 (10.6%) 35,628 (10.9%)
Vasoactive medication (n = 587,709) 214,398 (36.3%) 81,940 (31.7%) 132,458 (39.8%)
Renal replacement therapy (n = 575,376) 23,399 (4.1%) 8,688 (3.4%) 14,711 (4.6%)
Extracorporeal membrane oxygenation (n = 574,751) 1,580 (0.3%) 549 (0.2%) 1,031 (0.3%)
Any vital organ support (n = 609,329) 339,722 (55.1%) 131,493 (49.4%) 208,229 (59.5%)

APACHE = Acute Physiology and Chronic Health Evaluation, n = patients with complete data for each organ support.

Data are presented as number and percentage of patients, mean with sd, absolute difference in means (99% CI), or odds ratios (99% CI) (see Table E2, http://links.lww.com/CCM/H424, for further details).